|
|
|
Volumn 46, Issue 5, 2000, Pages 847-848
|
|
Quinolone-induced QT interval prolongation: A not-so-unexpected class effect [1]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CIPROFLOXACIN;
GATIFLOXACIN;
GREPAFLOXACIN;
LEVOFLOXACIN;
MOXIFLOXACIN;
OFLOXACIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
SITAFLOXACIN;
SPARFLOXACIN;
TROVAFLOXACIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
CARDIOTOXICITY;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DOG;
DRUG EFFECT;
DRUG INFORMATION;
DRUG LABELING;
DRUG MARKETING;
DRUG MONITORING;
DRUG PACKAGING;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
FOOD AND DRUG ADMINISTRATION;
GUINEA PIG;
HEART ARREST;
HEART MUSCLE;
HEART MUSCLE POTENTIAL;
HEART REPOLARIZATION;
HEART RIGHT VENTRICLE;
HEART VENTRICLE ARRHYTHMIA;
HEART VENTRICLE WALL;
HUMAN;
INCIDENCE;
LETTER;
LONG QT SYNDROME;
MAJOR CLINICAL STUDY;
MEDICAL DECISION MAKING;
NONHUMAN;
PRESCRIPTION;
PURKINJE FIBER;
RABBIT;
TORSADE DES POINTES;
UNITED STATES;
4-QUINOLONES;
ACTION POTENTIALS;
ANIMALS;
ANTI-INFECTIVE AGENTS;
HUMANS;
LONG QT SYNDROME;
POTASSIUM CHANNELS;
|
|
EID: 0033728034
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (26)
|
|
References (5)
|
